Literature DB >> 35022811

Dynamic susceptibility contrast-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between H3-mutant and H3-wild-type high-grade midline glioma.

Ryo Kurokawa1, Mariko Kurokawa2, Akira Baba2, Yoshiaki Ota2, John Kim2, Aristides Capizzano2, Ashok Srinivasan2, Toshio Moritani2.   

Abstract

OBJECTIVES: Diffuse midline gliomas, H3K27-altered (DMG-A), are malignant gliomas with an unfavorable prognosis. Knowledge of dynamic susceptibility contrast (DSC) MRI findings and imaging differences with high-grade midline glioma without H3K27 alteration (DMG-W) has been limited. We compared the DSC, ADC, and conventional MRI findings between DMG-A and DMG-W.
METHODS: In this single institutional retrospective study, the electronic database of our hospital between June 2015 and May 2021 was searched. Twenty and 17 patients with DMG-A (median, 13 years; range, 3-52 years; 11 females) and DMG-W (median, 40 years; 7-73 years; 9 females), respectively, were found. Normalized relative cerebral blood flow (nrCBF) and normalized corrected relative cerebral blood volume (ncrCBV); normalized maximum, mean, and minimum ADC values; and the prevalence of T2-FLAIR mismatch sign were compared between the two groups using Mann-Whitney U tests and Fisher's exact test.
RESULTS: The nrCBF and ncrCBV were significantly lower in DMG-A compared with DMG-W (nrCBF: median 0.88 [range, 0.19-2.67] vs. 1.47 [range, 0.57-4.90] (p < 0.001); ncrCBV: 1.17 [0.20-2.67] vs. 1.56 [0.60-4.03] (p = 0.008)). Normalized maximum ADC (nADCmax) was significantly higher in DMG-A (median 2.37 [1.25-3.98] vs. 1.95 [1.23-2.77], p = 0.02). T2-FLAIR mismatch sign was significantly more common in DMG-A (11/20 (55.0%) vs. 1/17 (5.9%), p = 0.0017). When at least two of nrCBF < 1.11, nADCmax ≥ 2.48, and T2-FLAIR mismatch sign were positive, the diagnostic performance was the highest with accuracy of 0.81.
CONCLUSION: DSC-MRI parameters, ADC values, and the T2-FLAIR mismatch sign are useful to differentiate between DMG-A and DMG-W. KEY POINTS: • Diffuse midline glioma, H3K27-altered (DMG-A), showed a significantly lower normalized relative cerebral blood flow and volume compared with H3K27-wild-type counterparts (DMG-W). • T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign was significantly more frequent in DMG-A compared to DMG-W. • Indicators that combined DSC parameters, ADC values, and T2-FLAIR mismatch sign, with or without age, are useful to distinguish the two tumors.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.

Entities:  

Keywords:  Child; Diffusion magnetic resonance imaging; Glioblastoma; Perfusion-weighted magnetic resonance imaging

Mesh:

Year:  2022        PMID: 35022811     DOI: 10.1007/s00330-021-08476-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  3 in total

1.  Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.

Authors:  M S Aboian; E Tong; D A Solomon; C Kline; A Gautam; A Vardapetyan; B Tamrazi; Y Li; C D Jordan; E Felton; B Weinberg; S Braunstein; S Mueller; S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-06       Impact factor: 3.825

2.  Response to letter to the editor by Moudgil-Joshi and Kaliaperumal.

Authors:  David N Louis; Ian A Cree
Journal:  Neuro Oncol       Date:  2021-12-01       Impact factor: 13.029

3.  Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults.

Authors:  Jessica D Schulte; Robin A Buerki; Sarah Lapointe; Annette M Molinaro; Yalan Zhang; Javier E Villanueva-Meyer; Arie Perry; Joanna J Phillips; Tarik Tihan; Andrew W Bollen; Melike Pekmezci; Nicholas Butowski; Nancy Ann Oberheim Bush; Jennie W Taylor; Susan M Chang; Philip Theodosopoulos; Manish K Aghi; Shawn L Hervey-Jumper; Mitchel S Berger; David A Solomon; Jennifer L Clarke
Journal:  Neurooncol Adv       Date:  2020-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.